A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of ABT-199
Phase of Trial: Phase I
Latest Information Update: 22 Nov 2017
Price : $35 *
At a glance
- Drugs Venetoclax (Primary) ; Ketoconazole
- Indications Non-Hodgkin's lymphoma
- Focus Pharmacokinetics
- Sponsors AbbVie
- 02 Nov 2016 Results published in the British Journal of Clinical Pharmacology
- 15 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Aug 2014 Planned End Date changed from 1 Sep 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.